Skip to main content

GUFICBIO · Gufic Biosciences Limited · Financials

473.05 INR -13.95 (-2.86%) At close · Nov 13
Market Cap
47.44B INR
Shares
100.28M
Volume · Nov 13 219.5K Avg daily vol (3M) 124.82K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
9.44B +15.2%
FY2026 Revenue FY2024–FY2026
Net Income
0
FY2026 Net Income FY2024–FY2026
Operating Cash Flow
449.68M -63.3%
FY2026 Operating Cash Flow FY2024–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024
INR 9.81B 9.44B 8.2B 8.07B
INR 308.2M 308.33M 210.65M 170.17M
INR 366.96M 366.11M 231.12M 153.6M
INR 993.14M 865.49M 941.43M 1.16B
INR 258.59M 223.36M 244.95M 295.36M
INR 223.13M 0 0 861.36M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 29.75M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.